Loading data...
TL Genomics Inc.
President and CEO
Tomohiro Kubo
Fertility and Biological Age Testing Service - A breakthrough service that measures aging at the cellular level to determine natural pregnancy potential.
Recent News & PR
Summary
Message to Participants
Detailed Information
TL Genomics Inc. provides a pregnancy power testing service that measures the degree of aging at the cellular level and assesses natural pregnancy potential. Additionally, we have developed a new chromosome testing technology, SinChro™, based on PCR and are also working on the development of in vitro diagnostic pharmaceuticals.
Unfair Advantage & Strengths
N/A
Competitors
N/A
Company Profile
事業カテゴリ
Healthcare / Biotech
本社所在地
Nagaizumi-cho, Sunto-gun, Shizuoka, Japan
設立日
2015/01/09
資本金
N/A
Employee Count
2
Industry Outlook & Trends for TL Genomics Inc.
Driven by aging populations and rising healthcare costs, the healthcare and biotech market where TL Genomics Inc. operates is growing globally. Telemedicine, digital health via wearables, AI-driven drug discovery, and gene therapy are advancing rapidly. The industry is shifting from treatment to prevention, increasing demand for highly personalized health solutions like those developed by TL Genomics Inc..
🔒
VPO Investor Pro Features
You are viewing a basic startup profile. Create a free account to access the dashboard. You can also upgrade to the "Investor Pro" plan to unlock full access to the following premium databases and features:
🎬
Elevator & Full Pitch Video
Watch full presentations with English/Japanese subtitles.
📊
AI Quick Report & Valuation
Get AI-driven assessment scores on market, product, and traction.
📅
Priority Challenges & Hiring
Access core corporate bottlenecks and current hiring plans.
📝
Full Transcripts
Read full pitch dialogue in both English and Japanese.
📈
Financials & Exit Strategy
Unlock IPO/M&A timelines and debt/equity plans.
👥
Advisors & Key Members
View internal team details and advisory board configurations.